Overview

High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy between 1-day high dose PPI-based triple therapy vs. 10-day sequential therapy for Helicobacter pylori eradication in functional dyspepsia patients.
Phase:
Phase 4
Details
Lead Sponsor:
Mahidol University
Collaborator:
Takeda Pharmaceuticals International, Inc.
Treatments:
Amoxicillin
Clarithromycin
Lansoprazole